スポンサーリンク
First Department of Surgery, Tohoku University School of Medicine | 論文
- P-498 LOCAL DELIVERY OF INTERLEUKIN 12 INDUCES ANTI-ANGIOGENESIS EFFECT : A POSSIBLE APPROACH FOR PANCREATIC CANCER THERAPY
- Gene therapy for pancreatic cancer based on genetic characterization of the disease
- The Antiangiogenesis Effect of Interleukin 12 During Early Growth of Human Pancreatic Cancer in SCID Mice
- Nationwide epidemiological survey of chronic pancreatitis in Japan
- Trends in treatment for pancreatic cancer
- Surgery Versus Radiochemotherapy for Resectable Locally Invasive Pancreatic Cancer : Final Results of a Randomized Multi-Institutional Trial
- Continuous regional arterial infusion (CRAI) therapy reduces the mortality rate of acute necrotizing pancreatitis : results of a cooperative survey in Japan
- A patient with multiple endocrine neoplasia type 1 with a novel MEN1 gene mutation (237delC)
- Acute pancreatitis complicating ulcerative colitis under administration of corticosteroid in surgical cases
- Long-Term Bile Diversion Enhances Basal and Duodenal Oleate-Stimulated Pancreatic Exocrine Secretion in Dogs
- Laparoscope-Assisted Versus Conventional Restorative Proctocolectomy with Rectal Mucosectomy
- The Role of Lipid Peroxidation on Gastric Mucosal Lesions Induced by Water-Immersion-Restraint Stress in Rats
- Management of Urinary Complications in Crohn's Disease
- CD44H Participates in the Intrahepatic Growth of Murine Colon 26 Adenocarcinoma Cells
- Surgical Aspect of Enteroinsular Axis After Gastrointestinal Surgery with Reference to Incretin Secretion
- Psoas Abscess Complicating Crohn's Disease : Report of Two Cases
- Cloning and characterization of the human UDP-N-acetylglucosamine : α-1,3-D-mannoside β-1,4-N-acetylglucosaminyltransferase IV-homologue (hGnT-IV-H) gene
- Efficient Construction of a Diabody Using a Refolding System : Anti-Carcinoembryonic Antigen Recombinant Antibody Fragment
- Restricted replication-competent adenovirus: a novel strategy for cancer gene therapy
- Granulocyte-colony stimulating factor-producing esophageal carcinoma: serum level as a marker for monitoring the effects of treatment